Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 364240, 11 pages
http://dx.doi.org/10.1155/2012/364240
Research Article

Expression of GA733-Fc Fusion Protein as a Vaccine Candidate for Colorectal Cancer in Transgenic Plants

1Department of Medicine, Medical Research Institute, College of Medicine, Chung-Ang University, Seoul 156-756, Republic of Korea
2Division of Biological Science, College of Natural Sciences, Wonkwang University, Iksan, Jeonbuk 570-749, Republic of Korea
3Korea Research Institute of Bioscience & Biotechnology, Daejeon 305-806, Republic of Korea
4Department of Agrofood Resources, National Academy of Agricultural Science, RDA, Suwon, Gyeonggi-do 441-707, Republic of Korea
5Department of Applied Biology, College of Agriculture & Life Science, Chonnam National University, Gwangju 500-757, Republic of Korea

Received 5 December 2011; Revised 19 February 2012; Accepted 10 March 2012

Academic Editor: Nathan A. Ellis

Copyright © 2012 Zhe Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Neighbors, D. Apt, J. C. C. Chang et al., “EpCAM-specific vaccine response by modified antigen and chimeric costimulatory molecule in cynomolgus monkeys,” Journal of Immunotherapy, vol. 31, no. 7, pp. 644–655, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Andrianov, R. Brodzik, S. Spitsin et al., “Production of recombinant anthrax toxin receptor (ATR/CMG2) fused with human Fc in planta,” Protein Expression and Purification, vol. 70, no. 2, pp. 158–162, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Armstrong and S. L. Eck, “EpCAM: a new therapeutic target for an old cancer antigen,” Cancer Biology and Therapy, vol. 2, no. 4, pp. 320–325, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Du, H. Ji, S. Cao et al., “EpCAM: a potential antimetastatic target for gastric cancer,” Digestive Diseases and Sciences, vol. 55, no. 8, pp. 2165–2171, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Munz, P. A. Baeuerle, and O. Gires, “The emerging role of EpCAM in cancer and stem cell signaling,” Cancer Research, vol. 69, no. 14, pp. 5627–5629, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Verch, D. C. Hooper, A. Kiyatkin, Z. Steplewski, and H. Koprowski, “Immunization with a plant-produced colorectal cancer antigen,” Cancer Immunology, Immunotherapy, vol. 53, no. 2, pp. 92–99, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Yusibov and S. Rabindran, “Recent progress in the development of plant-derived vaccines,” Expert Review of Vaccines, vol. 7, no. 8, pp. 1173–1183, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Góra-Sochacka, P. Redkiewicz, B. Napiórkowska, and A. Sirko, “Plant-based production of recombinant cytokines,” Postepy Biochemii, vol. 55, no. 1, pp. 85–94, 2009. View at Google Scholar · View at Scopus
  9. R. Brodzik, S. Spitsin, M. Golovkin et al., “Plant-derived EpCAM antigen induces protective anti-cancer response,” Cancer Immunology, Immunotherapy, vol. 57, no. 3, pp. 317–323, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Ko, M. H. Ahn, M. Song et al., “Glyco-engineering of biotherapeutic proteins in plants,” Molecules and Cells, vol. 25, no. 4, pp. 494–503, 2008. View at Google Scholar · View at Scopus
  11. K. Ko, Y. Tekoah, P. M. Rudd et al., “Function and glycosylation of plant-derived antiviral monoclonal antibody,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 13, pp. 8013–8018, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Ko and H. Koprowski, “Plant biopharming of monoclonal antibodies,” Virus Research, vol. 111, no. 1, pp. 93–100, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Munro and H. R. B. Pelham, “A C-terminal signal prevents secretion of luminal ER proteins,” Cell, vol. 48, no. 5, pp. 899–907, 1987. View at Google Scholar · View at Scopus
  14. S. Amigorena and C. Bonnerot, “Fc receptors for IgG and antigen presentation on MHC class I and class II molecules,” Seminars in Immunology, vol. 11, no. 6, pp. 385–390, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Brodzik, M. Glogowska, K. Bandurska et al., “Plant-derived anti-Lewis Y mAb exhibits biological activities for efficient immunotherapy against human cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 23, pp. 8804–8809, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. K. M. Lo, Y. Sudo, J. Chen et al., “High level expression and secretion of Fc-X fusion proteins in mammalian cells,” Protein Engineering, vol. 11, no. 6, pp. 495–500, 1998. View at Google Scholar · View at Scopus
  17. A. Ashkenazi and S. M. Chamow, “Immunoadhesins as research tools and therapeutic agents,” Current Opinion in Immunology, vol. 9, no. 2, pp. 195–200, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Ko, X. Wei, P. A. Crooks, and H. Koprowski, “Elimination of alkaloids from plant-derived human monoclonal antibody,” Journal of Immunological Methods, vol. 286, no. 1-2, pp. 79–85, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. K. J. Lee, J. H. Jung, J. M. Lee et al., “High-throughput quantitative analysis of plant N-glycan using a DNA sequencer,” Biochemical and Biophysical Research Communications, vol. 380, no. 2, pp. 223–229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. A. Goetz, M. V. Novotny, and Y. Mechref, “Enzymatic/chemical release of O-glycans allowing MS analysis at high sensitivity,” Analytical Chemistry, vol. 81, no. 23, pp. 9546–9552, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Schouten, J. Rossien, F. A. Van Engelen et al., “The C-terminal KDEL sequence increases the expression level of a single-chain antibody designed to be targeted to both the cytosol and the secretory pathway in transgenic tobacco,” Plant Molecular Biology, vol. 30, no. 4, pp. 781–793, 1996. View at Google Scholar · View at Scopus
  22. C. I. Wandelt, M. R. I. Khan, S. Craig, H. E. Schroeder, D. Spencer, and T. J. V. Higgins, “Vicilin with carboxy-terminal KDEL is retained in the endoplasmic reticulum and accumulates to high levels in the leaves of transgenic plants,” The Plant Journal, vol. 2, no. 2, pp. 181–192, 1992. View at Google Scholar · View at Scopus
  23. M. L. Flanagan, R. S. Arias, P. Hu, L. A. Khawli, and A. L. Epstein, “Soluble Fc fusion proteins for biomedical research,” Methods in Molecular Biology, vol. 378, pp. 33–52, 2007. View at Google Scholar · View at Scopus
  24. V. Apostolopoulos, “Role of the mannose receptor in the immune response,” Current Molecular Medicine, vol. 1, no. 4, pp. 469–474, 2001. View at Google Scholar · View at Scopus